A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

Clinical trial NCT07343778 · COMPLETED

Trial details

NCT number: NCT07343778
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B With Hepatic Fibrosis

Start date: 2026-03-16
Primary completion: 2026-07-28
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.